Exercise training is one of the central components of cardiac rehabilitation for people with coronary artery disease, including patients recovering from a heart attack, angioplasty, stent placement, or bypass surgery. Regular, supervised exercise can improve aerobic capacity, vascular function, quality of life, and long-term cardiovascular prognosis. Yet the response to training varies substantially between individuals. While many patients become fitter, a considerable proportion—often estimated at one in five or more—experience minimal change in peak oxygen uptake, commonly written as V̇O₂peak. This measurement reflects the maximum amount of oxygen the body can use during intense exercise and is considered one of the most important indicators of cardiorespiratory fitness. Low or unchanged V̇O₂peak is associated with poorer functional capacity and a higher risk of future cardiovascular complications.

The study included 353 patients with coronary artery disease who completed three to four weeks of inpatient cardiac rehabilitation. The participants had experienced a heart attack or undergone coronary procedures such as angioplasty or bypass surgery. At the beginning of rehabilitation, the research team collected data from cardiopulmonary exercise testing and pulse wave analysis, together with standard demographic and clinical information. Cardiopulmonary exercise testing measures how the heart, lungs, blood vessels, and muscles respond while a person exercises, typically on a bicycle or treadmill. Pulse wave analysis provides non-invasive information about the movement of pressure waves through the arteries, including pulse wave velocity, a widely used indicator of arterial stiffness. The researchers then used baseline information to predict whether each patient would achieve a clinically meaningful improvement in V̇O₂peak by the end of rehabilitation.

Ten machine-learning algorithms were evaluated, including approaches designed to identify complex and non-linear relationships among multiple clinical variables. The strongest results came from a Random Forest model, an ensemble method that combines the predictions of many decision trees. Each tree evaluates the data through a series of branching decisions, while the final model aggregates their outputs to produce a more stable prediction. This approach can be particularly useful in medical datasets where several biological factors interact and where a single variable rarely determines the outcome on its own. In this study, the model correctly classified responders and non-responders 77% of the time. Although that level of accuracy is not sufficient to replace clinical judgment, it suggests that routinely collected physiological data may contain signals that are invisible when patients are assessed using conventional risk factors alone.

The most surprising finding was that responders and non-responders appeared broadly similar at the start of rehabilitation when judged by standard clinical characteristics. Age, sex, body mass index, baseline fitness, and aspects of medical history did not reliably separate the two groups. Explainable artificial-intelligence analysis, using a technique known as SHAP, helped reveal which variables contributed most strongly to the model’s predictions. SHAP, or Shapley Additive Explanations, estimates how much each feature pushes an individual prediction toward one outcome or another. Rather than treating the algorithm as a black box, this method allows researchers to examine the relative influence of physiological measurements and understand why a particular patient may be predicted to respond poorly.

The most influential predictors were linked to breathing efficiency during exercise and the condition of the arteries. Patients who required more ventilation to consume a given amount of oxygen were less likely to achieve a substantial improvement in aerobic capacity. This relationship can be expressed through the ventilatory equivalent for oxygen, which describes how much air a person must move through the lungs for each unit of oxygen taken up by the body. A higher value may indicate that breathing is less efficient during exercise or that the circulation and respiratory systems are working under greater physiological strain. Reduced breathing reserve—the limited capacity remaining between exercise ventilation and the maximum ventilatory ability of the lungs—also contributed to predictions of a weaker training response.

Arterial stiffness provided another important signal. Patients with higher pulse wave velocity were less likely to improve their V̇O₂peak after standard rehabilitation. Healthy arteries expand and recoil as blood is pumped from the heart, helping regulate pressure and maintain efficient blood flow. Stiffer arteries transmit pressure waves more rapidly and can increase the workload placed on the heart while impairing the delivery of blood to working muscles. These vascular limitations may help explain why two patients with similar age, medical history, and baseline exercise capacity can respond very differently to the same training program. The model also identified the use of angiotensin II receptor blockers and calcium channel blockers as factors that influenced predictions, although the study does not establish that these medications directly caused a reduced response.

The findings suggest that the biology of exercise adaptation may be more individualized than traditional rehabilitation models assume. A standard aerobic program can produce strong benefits for many patients, but those with impaired vascular elasticity or inefficient ventilatory responses may require a different dose, intensity, duration, or progression of exercise. Instead of waiting until the end of rehabilitation to measure whether a patient has improved, clinicians could eventually use baseline pulse wave and exercise-test data to identify people who need closer monitoring or an adjusted program. Such interventions might include more carefully controlled aerobic intervals, longer training periods, additional resistance exercise, or treatment of underlying vascular and respiratory limitations. The researchers emphasize that the model is intended to support—not replace—medical decision-making.

Professor Boris Schmitz and Professor Frank Mooren of the University of Witten/Herdecke led the study in collaboration with researchers from DRV Clinic Königsfeld in Germany and FORTH in Greece. The team’s next step is a randomized controlled trial examining whether patients predicted to be non-responders can benefit from individually adjusted aerobic interval training. That experiment will be critical because prediction alone does not demonstrate that changing treatment will improve outcomes. A model may identify a group at higher risk of limited improvement, but only prospective testing can show whether acting on that information leads to greater gains in fitness, better symptoms, or improved cardiovascular health.

The researchers also caution that the current results should not yet be generalized to every cardiac rehabilitation population. The model was developed using patients treated in a specific clinical setting and may perform differently in older adults, people with multiple chronic conditions, or those completing outpatient programs with different exercise schedules. It will need external validation in larger and more diverse groups before it can be integrated into routine care. Even so, the study offers a compelling glimpse of how artificial intelligence could transform rehabilitation: not by replacing exercise, but by helping clinicians determine which kind of exercise is most likely to work for each patient. If future trials confirm the approach, a simple combination of cardiopulmonary exercise testing and pulse wave analysis could help prevent patients from completing rehabilitation without achieving meaningful improvements in cardiovascular fitness.

Subject of Research: People with coronary artery disease undergoing exercise-based cardiac rehabilitation

Article Title: A machine learning approach predicts improvement of physical exercise capacity based on pulse wave analysis in coronary artery disease patients

News Publication Date: 5 May 2026

Web References: https://doi.org/10.1016/j.jshs.2026.101144

References: Journal of Sport and Health Science; DOI: 10.1016/j.jshs.2026.101144

Image Credits: Hendrik Schäfer, University of Witten/Herdecke, Germany

Keywords: cardiac rehabilitation, coronary artery disease, machine learning, Random Forest, exercise response, non-responders, cardiopulmonary exercise testing, pulse wave analysis, arterial stiffness, V̇O₂peak, personalized medicine, cardiovascular health

Heart disease diagnosis has historically relied on a combination of clinical judgment, patient history, and standard diagnostic tests such as electrocardiograms, echocardiograms, and blood work. However, the complex multifactorial nature of heart disease complicates straightforward prediction, as it involves numerous interrelated risk factors with varying degrees of influence. Traditional predictive models often struggle with balancing these factors and handling inherent uncertainties in clinical data, leading to false positives or negatives that can have serious implications.

The new framework presented by Wang, Fan, Yu, and colleagues addresses these limitations head-on by embedding uncertainty quantification directly into the feature weighting mechanism within an ensemble model structure. Ensemble models combine predictions from multiple algorithms to improve overall performance, but not all features contribute equally, and not all features’ contributions are certain. By incorporating an uncertainty-aware approach, the system dynamically adjusts the weighting of features based on the confidence level in the data, refining prediction accuracy.

This research leverages a combination of advanced machine learning techniques and probabilistic modeling. The ensemble framework integrates multiple base learners, each trained on different subsets of the data and features, ensuring diverse perspectives on the prediction task. Importantly, the model estimates uncertainty for each feature’s contribution by evaluating variability and noise within the input data, an approach inspired by Bayesian principles but optimized for practical large-scale clinical datasets.

The implication of this methodology is profound. In real-world clinical scenarios, data can be incomplete, noisy, or inconsistent, and patient heterogeneity further complicates matters. An uncertainty-aware predictive framework explicitly acknowledges these imperfections, allowing clinicians to interpret predictions with a calibrated understanding of confidence intervals rather than absolute binaries. This represents a critical advance toward responsible AI deployment in medicine, where risk and uncertainty must be transparently communicated.

To validate their framework, the researchers utilized comprehensive cardiovascular datasets encompassing diverse patient demographics, clinical histories, lab results, and imaging findings. The model was rigorously compared against standard machine learning classifiers widely used in this domain. Results demonstrated not only superior predictive performance but also enhanced robustness against overfitting and sensitivity to data anomalies, underlining the practical viability of the approach.

Beyond accuracy, the ensemble’s feature weighting provides valuable insights into the relative importance of various risk factors for individual patients. This personalized risk profiling can assist physicians in tailoring preventive interventions or treatment plans. The interpretability of the model’s outputs—in terms of which features most influenced the risk estimate—addresses a key concern in clinical AI applications: explainability.

Furthermore, the framework’s scalable architecture enables easy adaptation and retraining as new clinical data becomes available or as heart disease pathophysiology understanding evolves. This adaptability is crucial for maintaining model relevance in a rapidly changing medical environment and for harnessing continuous learning from new patient cohorts or emerging diagnostic modalities.

The study’s authors emphasize that integrating uncertainty quantification in predictive modeling is not only a technical exercise but also an ethical imperative. Misdiagnosis or missed disease detection carries significant consequences, and delivering risk predictions with quantified uncertainty aids clinicians in decision-making under ambiguity. This can translate into better patient outcomes, more efficient resource allocation, and ultimately decreased healthcare costs.

One of the innovative aspects of this framework is its potential applicability beyond heart disease. The underlying principles of uncertainty-aware feature weighting can be transferred to other complex conditions where multifactorial interactions and imperfect data are the norm, such as cancer diagnostics, neurological disorders, or metabolic syndromes. Thus, this work may catalyze a broader paradigm shift in clinical AI.

Critics of AI in healthcare often highlight the “black box” nature of many predictive algorithms, causing mistrust among practitioners and patients alike. The proposed ensemble framework counters this by explicitly modeling uncertainty and clarifying feature contributions, fostering transparency. This transparent risk stratification aligns with contemporary moves towards patient-centric AI, where understanding model rationale enhances acceptance and adherence.

Moreover, the authors discuss integration pathways with existing electronic health record (EHR) systems, suggesting practical deployment in clinical settings without major disruptions. Their modular design ensures seamless interfacing with hospital data infrastructures and real-time updating, enabling continuous decision support during patient consultations.

While this framework marks a substantial advance, the researchers acknowledge several avenues for further refinement. Incorporating longitudinal data to capture disease progression, integrating genomic or proteomic biomarkers, and enhancing interpretative visualizations remain promising directions. Additionally, prospective clinical trials will be essential to evaluate the model’s impact on patient management and outcomes in real-world settings.

The significance of this study extends to public health initiatives as well. Improved prediction tools empower earlier identification of high-risk individuals, facilitating timely interventions that can reduce heart disease incidence on a population scale. By embedding uncertainty awareness, public health policies can incorporate more nuanced risk thresholds, optimizing preventive strategies.

In conclusion, the uncertainty-aware feature-weighted ensemble framework devised by Wang and colleagues represents a landmark evolution in heart disease prediction technologies. By marrying robust machine learning architectures with probabilistic reasoning, this framework not only enhances predictive accuracy but also fosters transparency and ethical responsibility in AI-driven healthcare. As cardiology continues to embrace digital innovation, such advances herald a new era of precision medicine that is both data-driven and human-centered.

Subject of Research: Heart disease prediction using advanced machine learning frameworks.

Article Title: Uncertainty-aware feature-weighted ensemble framework for heart disease prediction.

Article References:
Wang, X., Fan, Y., Yu, M. et al. Uncertainty-aware feature-weighted ensemble framework for heart disease prediction. Sci Rep (2026). https://doi.org/10.1038/s41598-026-42419-w

Image Credits: AI Generated